Randoncorp (RAPT4) Stock Overview
Manufactures and sells trailers and semi-trailers, and auto parts in Latin America and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
RAPT4 Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Randoncorp S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$4.57 |
| 52 Week High | R$9.00 |
| 52 Week Low | R$4.18 |
| Beta | 0.13 |
| 1 Month Change | -11.78% |
| 3 Month Change | -14.10% |
| 1 Year Change | -46.98% |
| 3 Year Change | -62.45% |
| 5 Year Change | -66.32% |
| Change since IPO | 9,863.81% |
Recent News & Updates
Narrative Update • Jun 24
RAPT4: Higher Margin Framework And Lower Future P/E Will Support Upside
Analysts have revised their Randoncorp price target to R$10.00, down from R$10.90, citing updated assumptions for revenue growth, profit margin and a lower future P/E multiple. What’s in the News for Randoncorp Randoncorp held an Analyst/Investor Day, providing updates directly to the market on its business and outlook for stakeholders.
Narrative Update • Jun 09
RAPT4: Future Execution Following Investor Day Will Drive Margin Delivery
Analysts have trimmed their price target for Randoncorp to R$5.50 from R$5.85, citing updated assumptions that include a slightly higher discount rate, modest adjustments to revenue growth expectations, a small change in profit margin forecasts, and a lower future P/E multiple. What's in the News Randoncorp held an Analyst/Investor Day, giving the market an updated look at its business and plans.
Narrative Update • May 26
RAPT4: Higher Growth Assumptions And Lower Multiple May Support Future Repricing
Analysts have revised Randoncorp's fair value estimate from R$9.25 to R$8.00, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple. What's in the News Randoncorp held an Analyst/Investor Day, giving the market an opportunity to hear updated management views and assumptions directly from the company (Key Developments).Narrative Update • May 03
RAPT4: Future Margin Delivery And Execution At Investor Day Will Matter
Analysts have revised their fair value estimate for Randoncorp from R$7.00 to R$5.85, citing updated assumptions for revenue growth, profit margins, and future P/E multiples as reflected in recent Street research. Analyst Commentary Bearish analysts are treating the cut in fair value from R$7.00 to R$5.85 as a signal that the risk and reward trade off for Randoncorp has become less attractive under current assumptions.Narrative Update • Apr 18
RAPT4: Execution On Margin Reset And Higher P/E Will Sustain Equity Confidence
Randoncorp's updated analyst price target edges slightly lower to R$10.90 from R$10.96, as analysts factor in a reduced profit margin outlook along with a higher assumed future P/E multiple, while keeping revenue growth and discount rate assumptions broadly in line with prior estimates. Analyst Commentary Analysts reviewing Randoncorp's revised assumptions see the modest trim in the price target to R$10.90 as largely technical, tied to updated margin expectations and valuation inputs rather than a shift in the core business outlook.Recent updates
Narrative Update • Jun 24
RAPT4: Higher Margin Framework And Lower Future P/E Will Support Upside
Analysts have revised their Randoncorp price target to R$10.00, down from R$10.90, citing updated assumptions for revenue growth, profit margin and a lower future P/E multiple. What’s in the News for Randoncorp Randoncorp held an Analyst/Investor Day, providing updates directly to the market on its business and outlook for stakeholders.Narrative Update • Jun 09
RAPT4: Future Execution Following Investor Day Will Drive Margin Delivery
Analysts have trimmed their price target for Randoncorp to R$5.50 from R$5.85, citing updated assumptions that include a slightly higher discount rate, modest adjustments to revenue growth expectations, a small change in profit margin forecasts, and a lower future P/E multiple. What's in the News Randoncorp held an Analyst/Investor Day, giving the market an updated look at its business and plans.Narrative Update • May 26
RAPT4: Higher Growth Assumptions And Lower Multiple May Support Future Repricing
Analysts have revised Randoncorp's fair value estimate from R$9.25 to R$8.00, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple. What's in the News Randoncorp held an Analyst/Investor Day, giving the market an opportunity to hear updated management views and assumptions directly from the company (Key Developments).Narrative Update • May 03
RAPT4: Future Margin Delivery And Execution At Investor Day Will Matter
Analysts have revised their fair value estimate for Randoncorp from R$7.00 to R$5.85, citing updated assumptions for revenue growth, profit margins, and future P/E multiples as reflected in recent Street research. Analyst Commentary Bearish analysts are treating the cut in fair value from R$7.00 to R$5.85 as a signal that the risk and reward trade off for Randoncorp has become less attractive under current assumptions.Narrative Update • Apr 18
RAPT4: Execution On Margin Reset And Higher P/E Will Sustain Equity Confidence
Randoncorp's updated analyst price target edges slightly lower to R$10.90 from R$10.96, as analysts factor in a reduced profit margin outlook along with a higher assumed future P/E multiple, while keeping revenue growth and discount rate assumptions broadly in line with prior estimates. Analyst Commentary Analysts reviewing Randoncorp's revised assumptions see the modest trim in the price target to R$10.90 as largely technical, tied to updated margin expectations and valuation inputs rather than a shift in the core business outlook.Narrative Update • Apr 04
RAPT4: Future Margin Delivery Will Drive Re Rating Potential
Analysts have trimmed Randoncorp's fair value estimate to R$7.00 from R$7.50, reflecting updated assumptions around slightly higher revenue growth, improved profit margins, and a lower future P/E multiple. Analyst Commentary Recent Street research flow around comparables in other sectors shows how quickly sentiment can turn when expectations on growth, execution, or valuation come under pressure.Narrative Update • Mar 21
RAPT4: Execution And Margin Discipline Will Support Confidence In Updated Fair Value
Analysts have slightly reduced Randoncorp's fair value estimate, with the price target moving from R$11.00 to about R$10.96. This adjustment reflects updated views on revenue growth, profit margins and a lower assumed future P/E multiple.Narrative Update • Mar 07
RAPT4: Execution On Margin Assumptions Will Determine Future Upside Potential
Analysts have slightly adjusted their Randoncorp price target to R$7.50. This reflects updated views on discount rates, revenue growth assumptions and profit margins compared with prior estimates.Narrative Update • Feb 20
RAPT4: Margin And Risk Assumptions Will Support Confidence In Updated Fair Value
Analysts kept their R$11.00 fair value unchanged for Randoncorp, explaining that slightly lower revenue growth assumptions, a modestly stronger profit margin outlook, and a small cut to the discount rate helped balance the overall adjustment in their price target model. Analyst Commentary Recent commentary around Randoncorp points to analysts viewing the current R$11.00 fair value as broadly aligned with their updated assumptions, rather than a high conviction outlier in either direction.Narrative Update • Feb 06
RAPT4: Updated Fair Value Assumptions Will Support Medium Term Repricing Potential
Analysts have nudged their fair value estimate for Randoncorp to $9.25 from $9.03, citing updated assumptions that combine a slightly lower discount rate and future P/E with revised expectations for revenue growth and profit margins. Analyst Commentary Recent Street research around other high growth, research heavy companies gives some useful context for how analysts are thinking about valuation, execution risk, and growth assumptions that can also matter for Randoncorp.Narrative Update • Jan 23
RAPT4: Future Order Trends Will Drive Confidence In Updated Fair Value
Analysts have reduced their fair value estimate for Randoncorp from $16.00 to $11.00. They cited updated assumptions that include a slightly higher discount rate, more conservative revenue growth, a higher projected profit margin, and a lower future P/E multiple.Narrative Update • Jan 09
RAPT4: Urticaria Phase 2 Readout Will Drive Pipeline Upside Ahead
Analysts have trimmed their fair value estimate for Randoncorp by $0.35 to $9.03, reflecting slightly softer revenue growth assumptions, offset in part by a marginally higher profit margin outlook and a modestly lower future P/E assumption. Analyst Commentary Recent Street research has focused heavily on Rapt Therapeutics rather than Randoncorp directly, but it still offers a useful reference point for how analysts are thinking about valuation, execution risk, and growth opportunities in high conviction situations.Narrative Update • Dec 24
RAPT4: Earnings Delivery Will Drive Upside Despite Mixed Market Backdrop
Analysts have raised their price target on Randoncorp to reflect a richer future earnings multiple and slightly higher margins, even as they temper long term growth assumptions and apply a marginally higher discount rate. Analyst Commentary Despite the recent upward revision to Randoncorp's price target, investor conversations reflect a more mixed backdrop than the headline number suggests.Narrative Update • Dec 10
RAPT4: Phase 2 Urticaria Milestone Will Drive Further Upside Ahead
Analysts have nudged Randoncorp's fair value estimate higher to $9.38 from $9.23, citing modestly stronger profit margin expectations and a lower projected future P/E multiple. Together, these factors support a slightly higher price target despite largely unchanged growth and risk assumptions.Narrative Update • Nov 26
RAPT4: Phase 2 Chronic Urticaria Progress Will Drive Further Upside After 27% Rally
Randoncorp's analyst price target has surged dramatically, with new projections rising to $72 from $27. Analysts cite strong clinical data and increased confidence in key programs as primary drivers of this upward revision.Narrative Update • Nov 12
RAPT4: Phase 2 Data Will Drive Shares Higher After 27% Rally
Analysts have sharply raised their price target for Randoncorp, with recent increases of as much as $45 per share. They cite strong Phase 2 clinical data and growing confidence in the company’s expanding therapeutic pipeline.Narrative Update • Oct 29
Fleet Renewal Momentum And Index Inclusion Will Drive Long-Term Market Prominence
Randoncorp's analyst price target has been revised downward from $9.83 to $9.23 per share, as analysts cite lower projected revenue growth and profit margins in their updated fair value assessment. Analyst Commentary Following the revision in price target for Randoncorp, recent commentary from the analyst community highlights both optimism and lingering caution around the company's outlook.Narrative Update • Oct 15
Brazil Fleet Renewal And Global Exports Will Ignite Positive Transformation
Randoncorp's analyst price target has been revised downward from $10.74 to $9.83 per share. Analysts cite a more cautious outlook on profit margins, despite modestly improved revenue growth expectations.Narrative Update • Sep 16
Brazil Fleet Renewal And Global Exports Will Ignite Positive Transformation
The consensus analyst price target for Randoncorp has been reduced primarily due to a lower forward P/E multiple, while revenue growth forecasts remain stable, resulting in a new fair value estimate of R$10.74. What's in the News Randoncorp added to the Brazil IBRX Index.
New Narrative • Jan 17
AT4T Autonomous Tech To Improve Efficiency Across Agriculture, Logistics, And Mining
Randoncorp's advancements in autonomous technology and electric systems position it as a leader in mobility, potentially driving future revenue growth.Shareholder Returns
| RAPT4 | BR Machinery | BR Market | |
|---|---|---|---|
| 7D | -4.0% | -0.7% | 2.8% |
| 1Y | -47.0% | -20.6% | 13.6% |
Return vs Industry: RAPT4 underperformed the BR Machinery industry which returned -20.6% over the past year.
Return vs Market: RAPT4 underperformed the BR Market which returned 13.6% over the past year.
Price Volatility
| RAPT4 volatility | |
|---|---|
| RAPT4 Average Weekly Movement | 5.4% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 7.9% |
| 10% least volatile stocks in BR Market | 1.9% |
Stable Share Price: RAPT4 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: RAPT4's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 17,300 | Daniel Randon | www.randoncorp.com/pt/ |
Randoncorp S.A. manufactures and sells trailers and semi-trailers, and auto parts in Latin America and internationally. The company offers bodies, trailers, semi-trailers, and railcars; auto parts, including axles and suspensions to truck, bus, and implement manufacturers; truck, bus, trailer and semi-trailer brakes; commercial vehicle coupling components and systems; and hub and drum assemblies and cast steel brackets for the axles and suspensions of buses, trucks, trailers, farm machines, and tractors, as well as wheel end system solutions. It also provides financial solutions and services comprising financing, investments, consortium plans, insurance, and heavy vehicle leasing to transportation, logistics, agribusiness, and retail sectors.
Randoncorp S.A. Fundamentals Summary
| RAPT4 fundamental statistics | |
|---|---|
| Market cap | R$1.59b |
| Earnings (TTM) | -R$290.86m |
| Revenue (TTM) | R$13.04b |
0.1x
P/S Ratio-5.5x
P/E RatioIs RAPT4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RAPT4 income statement (TTM) | |
|---|---|
| Revenue | R$13.04b |
| Cost of Revenue | R$9.77b |
| Gross Profit | R$3.27b |
| Other Expenses | R$3.56b |
| Earnings | -R$290.86m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 13, 2026
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 25.08% |
| Net Profit Margin | -2.23% |
| Debt/Equity Ratio | 207.3% |
How did RAPT4 perform over the long term?
See historical performance and comparisonDividends
8.0%
Current Dividend Yield73%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/28 13:57 |
| End of Day Share Price | 2026/06/26 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Randoncorp S.A. is covered by 15 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | BB Banco de Investimento S.A. |
| Gabriel Frazao | BofA Global Research |
| Daniel Federle | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |